Interestingly, it has previously been demonstrated that STAT3 activation had a hepatoprotective role in a severe NASH model [41] and that STAT3 is a negative regulator of bile acid synthesis and provides protection from bile acid-induced apoptosis [42]. Here, STAT3 is linked to metabolic dysfunction-associated steatohepatitis.